Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

By D. Lloyd‐Jones, R. Adams, M. Carnethon, G. de Simone, T. Bruce Ferguson, K. Flegal, E. Ford, K. Furie, Alan S. Go, K. Greenlund and 25 more. Circulation, 2009

3,993 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/551037ad032fdd725024787a1979eb5ab78e944d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “The prevalence of HF is increasing steadily (50), likely because of aging of the population and improved survival with newer cardiovascular therapies.”
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond (2010, methodology): “EMS-treated cardiac arrest Annual incidence ROC, CARES, NEMSIS Experience cardiac arrest outside the hospital, are evaluated by organized EMS personnel, and (1) receive attempts at external defibrillation (by lay responders or emergency personnel), or receive chest compressions by organized EMS pers”
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010, neutral): “Sample of Longitudinal Studies Reporting the Indepen symptomatic Populations Primary easurement(s) First Author (Year, Country) Type of Events Follow-Up (y) xercise capacity Gulati (2003, US) (296) All-cause death 8.4 xercise capacity Wei (1999, US) (298) CVD death and all-cause death 10 xercise cap”
Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. (2010, background): “The incidence of heart failure increases with age, affecting 3–4% of those over 45 years old, 5% of those aged between 60 and 69 years of age, and 10% of people over the age of 70 (Davies et al., 2001; AIHW, 2004; Thom et al., 2006; Lloyd-Jones et al., 2009).”
Economic burden of occupational injury and illness in the United States. (2011, background): “Recent estimates of costs for categories of circulatory disease and cancer (Rosamond et al. 2007) relied on data in the study by Rice, Hodgson, and Kopstein (1985).”